Pilot Study: Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women, an Open Label Study With Dose Escalation
Latest Information Update: 19 Jul 2018
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 11 Jul 2018 Planned End Date changed from 1 Apr 2019 to 1 Jun 2018.
- 11 Jul 2018 Planned primary completion date changed from 1 Apr 2019 to 1 Jun 2018.
- 11 Jul 2018 Status changed from recruiting to withdrawn prior to enrolment.